These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 25455299)

  • 1. Investigating the minimal important difference in ambulation in multiple sclerosis: a disconnect between performance-based and patient-reported outcomes?
    Schwartz CE; Ayandeh A; Motl RW
    J Neurol Sci; 2014 Dec; 347(1-2):268-74. PubMed ID: 25455299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal changes in self-reported walking ability in multiple sclerosis.
    Motl RW; Putzki N; Pilutti LA; Cadavid D
    PLoS One; 2015; 10(5):e0125002. PubMed ID: 25932911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal change in physical activity and its correlates in relapsing-remitting multiple sclerosis.
    Motl RW; McAuley E; Sandroff BM
    Phys Ther; 2013 Aug; 93(8):1037-48. PubMed ID: 23599354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal measurement invariance of the Multiple Sclerosis Walking Scale-12.
    Motl RW; McAuley E; Mullen S
    J Neurol Sci; 2011 Jun; 305(1-2):75-9. PubMed ID: 21474149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-life walking impairment in multiple sclerosis: preliminary comparison of four methods for processing accelerometry data.
    Sosnoff JJ; Goldman MD; Motl RW
    Mult Scler; 2010 Jul; 16(7):868-77. PubMed ID: 20534642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physical activity correlates with neurological impairment and disability in multiple sclerosis.
    Motl RW; Snook EM; Wynn DR; Vollmer T
    J Nerv Ment Dis; 2008 Jun; 196(6):492-5. PubMed ID: 18552627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of multiple sclerosis condition-specific measures to inform health policy decision-making: mapping from the MSWS-12 to the EQ-5D.
    Hawton A; Green C; Telford CJ; Wright DE; Zajicek JP
    Mult Scler; 2012 Jun; 18(6):853-61. PubMed ID: 22108867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of walking mobility on the measurement of physical activity using accelerometry in multiple sclerosis.
    Snook EM; Motl RW; Gliottoni RC
    Clin Rehabil; 2009 Mar; 23(3):248-58. PubMed ID: 19218299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Long-term application of the multiple sclerosis functional composite test in Debrecen, Hungary].
    Mezei Z; Bereczki D; Csiba L; Csépány T
    Ideggyogy Sz; 2006 Nov; 59(11-12):442-7. PubMed ID: 17203882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal analysis of physical activity and symptoms as predictors of change in functional limitations and disability in multiple sclerosis.
    Motl RW; McAuley E
    Rehabil Psychol; 2009 May; 54(2):204-10. PubMed ID: 19469611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Application of the Multiple Sclerosis Functional Composite in Debrecen].
    Mezei Z; Bereczki D; Csiba L; Csépány T
    Ideggyogy Sz; 2005 Mar; 58(3-4):113-8. PubMed ID: 15887414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proxy measurements in multiple sclerosis: agreement on different patient-reported outcome scales.
    Sonder JM; Bosma LV; van der Linden FA; Knol DL; Polman CH; Uitdehaag BM
    Mult Scler; 2012 Feb; 18(2):196-201. PubMed ID: 21908479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the six-minute walk in multiple sclerosis subjects and healthy controls.
    Goldman MD; Marrie RA; Cohen JA
    Mult Scler; 2008 Apr; 14(3):383-90. PubMed ID: 17942508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accuracy of the actibelt(®) accelerometer for measuring walking speed in a controlled environment among persons with multiple sclerosis.
    Motl RW; Weikert M; Suh Y; Sosnoff JJ; Pula J; Soaz C; Schimpl M; Lederer C; Daumer M
    Gait Posture; 2012 Feb; 35(2):192-6. PubMed ID: 21945386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing disability progression with the Multiple Sclerosis Functional Composite.
    Rudick RA; Polman CH; Cohen JA; Walton MK; Miller AE; Confavreux C; Lublin FD; Hutchinson M; O'Connor PW; Schwid SR; Balcer LJ; Lynn F; Panzara MA; Sandrock AW
    Mult Scler; 2009 Aug; 15(8):984-97. PubMed ID: 19667023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validity of minimal clinically important difference values for the multiple sclerosis walking scale-12?
    Motl RW; Learmonth YC; Pilutti LA; Dlugonski D; Klaren R
    Eur Neurol; 2014; 71(3-4):196-202. PubMed ID: 24457548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continued validation of the Symptom Inventory in multiple sclerosis.
    Motl RW; Schwartz CE; Vollmer T
    J Neurol Sci; 2009 Oct; 285(1-2):134-6. PubMed ID: 19592041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Confirmation and extension of the validity of the Multiple Sclerosis Walking Scale-12 (MSWS-12).
    Motl RW; Snook EM
    J Neurol Sci; 2008 May; 268(1-2):69-73. PubMed ID: 18061618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical meaning of walking speed as measured by the timed 25-foot walk in patients with multiple sclerosis.
    Cohen JA; Krishnan AV; Goodman AD; Potts J; Wang P; Havrdova E; Polman C; Rudick RA
    JAMA Neurol; 2014 Nov; 71(11):1386-93. PubMed ID: 25178496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lifestyle physical activity and walking impairment over time in relapsing-remitting multiple sclerosis: results from a panel study.
    Motl RW; McAuley E; Wynn D; Vollmer T
    Am J Phys Med Rehabil; 2011 May; 90(5):372-9. PubMed ID: 21389842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.